Rankings
▼
Calendar
BDSX Q1 2025 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$151M
Q1 2025 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$18M
+21.2% YoY
Gross Profit
$14M
79.4% margin
Operating Income
-$9M
-50.9% margin
Net Income
-$11M
-61.8% margin
EPS (Diluted)
$-1.60
QoQ Revenue Growth
-12.1%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$972,000
Balance Sheet
Total Assets
$86M
Total Liabilities
$75M
Stockholders' Equity
$11M
Cash & Equivalents
$18M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$15M
+21.2%
Gross Profit
$14M
$12M
+22.4%
Operating Income
-$9M
-$11M
+17.1%
Net Income
-$11M
-$14M
+18.5%
Revenue Segments
Diagnostic Tests
$16M
91%
Development Services
$2M
9%
← FY 2025
All Quarters
Q2 2025 →